Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study
- PMID: 38820260
- PMCID: PMC11142444
- DOI: 10.1371/journal.pone.0304507
Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study
Abstract
Introduction: The treatment response of multi-drug resistance tuberculosis (MDR-Tuberculosis) patients is mainly dictated by the sputum culture conversion. An earlier culture conversion is a remarkable indicator of the improvement in the treatment response. In this study, we aimed to determine the time to culture conversion and its associated factors among MDR-Tuberculosis patients in All Africa Leprosy, Tuberculosis and Rehabilitation Training Center (ALERT) Hospital, Addis Ababa, Ethiopia.
Methods: A retrospective cohort study was conducted on 120 MDR-Tuberculosis patients attending ALERT Hospital from 2018-2022. Kaplan-Meier methods were used to determine the time to initial sputum culture conversion. All relevant laboratory, socio-demographic characteristics, and other clinical data were collected by chart abstraction using a structure data extraction form. The log-rank test was used to determine the survival rate. To identify the predictors of culture conversion, bivariate and multivariate Cox proportional hazard regression analysis was used. The hazard ratio (HR) with a 95% confidence interval was used to estimate the effect of each variable on the initial culture conversion. A test with a P value of < 0.05 was considered statistically significant.
Results: From the total of 120 study participants, 89.2% (107/120) have shown a successful culture conversion. The median age of the participants was 30 years (IQR = 12). The study participants were followed for 408.6 person-months (34.05 person-years). The median time to initial sputum culture conversion was 80 days. The median time to initial sputum culture conversion among HIV-positive and HIV-negative participants was 61 days (IQR = 58-63.5) and 88 days (IQR = 75-91), respectively. HIV-negative and patients with previous treatment history were shown to be the predictor for a prolonged time to initial sputum culture conversion, (aHR = 0.24 (95% CI: 0.1-0.4), P value <0.001) and (aHR = 0.47 (95% CI: 0.31-0.71), P value <0.001) respectively.
Conclusion: The median time to sputum culture conversion for HIV positive was found to be 61 days in our study. Notably, patients with a history of previous anti-tuberculosis treatment, HIV-negative status, and higher bacillary load at baseline exhibited delayed culture conversion. These findings underscore the importance of considering such patient characteristics in the management of MDR-TB cases, as tailored interventions and close monitoring may lead to more favorable treatment outcomes. By identifying individuals with these risk factors early in the treatment process, healthcare providers can implement targeted strategies to optimize patient care and improve overall treatment success rates in MDR-TB management programs.
Copyright: © 2024 Abebe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.PLoS One. 2018 Jun 26;13(6):e0198080. doi: 10.1371/journal.pone.0198080. eCollection 2018. PLoS One. 2018. PMID: 29944658 Free PMC article.
-
Sputum culture conversion and its predictors among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia.Int Health. 2025 May 1;17(3):292-303. doi: 10.1093/inthealth/ihae059. Int Health. 2025. PMID: 39348935 Free PMC article.
-
Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14. Int J Tuberc Lung Dis. 2013. PMID: 23321297 Free PMC article.
-
Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis.Int J Infect Dis. 2020 Sep;98:230-236. doi: 10.1016/j.ijid.2020.06.029. Epub 2020 Jun 12. Int J Infect Dis. 2020. PMID: 32535296
-
Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis.BMC Infect Dis. 2024 Feb 7;24(1):169. doi: 10.1186/s12879-024-09009-5. BMC Infect Dis. 2024. PMID: 38326758 Free PMC article.
Cited by
-
Optimizing Drug-Resistant Tuberculosis Treatment Outcomes in a High HIV-Burden Setting: A Study of Sputum Conversion and Regimen Efficacy in Rural South Africa.Pathogens. 2025 Apr 30;14(5):441. doi: 10.3390/pathogens14050441. Pathogens. 2025. PMID: 40430760 Free PMC article.
-
Impact of isoniazid monoresistance on overall and vulnerable patient populations in Taiwan.Emerg Microbes Infect. 2024 Dec;13(1):2417855. doi: 10.1080/22221751.2024.2417855. Epub 2024 Oct 23. Emerg Microbes Infect. 2024. PMID: 39404086 Free PMC article.
References
-
- WHO. Global TUberculosis Report. 2023.
-
- Bagcchi SJTLM. WHO’s global tuberculosis report 2022. 2023;4(1):e20. - PubMed
-
- Vanino E, Granozzi B, Akkerman OW, Munoz-Torrico M, Palmieri F, Seaworth B, et al.. Update of drug-resistant tuberculosis treatment guidelines: A turning point. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2023;130 Suppl 1:S12-s5. doi: 10.1016/j.ijid.2023.03.013 - DOI - PubMed
-
- Assemie MA, Alene M, Petrucka P, Leshargie CT, Ketema DB. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis. International Journal of Infectious Diseases. 2020;98:230–6. doi: 10.1016/j.ijid.2020.06.029 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources